Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Palvella Therapeutics, Inc.
Market Cap
$1.85B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$1.84B
Operating Margin
2.61%
TTM Avg
3.43%
3Y Avg
5.52%
5Y Avg
6.07%
Market Cap
$1.85B
Operating Margin
-3084.76%
TTM Avg
-3233.57%
3Y Avg
-1812.12%
5Y Avg
-1208.08%
Market Cap
$1.88B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.82B
Operating Margin
-29.92%
TTM Avg
-9.23%
3Y Avg
-24.36%
5Y Avg
-44.57%
Market Cap
$1.82B
Operating Margin
29.46%
TTM Avg
25.49%
3Y Avg
21.64%
5Y Avg
22.06%
Market Cap
$1.89B
Operating Margin
-1.12%
TTM Avg
-4.89%
3Y Avg
-11.52%
5Y Avg
-13.12%
Market Cap
$1.80B
Operating Margin
50.14%
TTM Avg
6.82%
3Y Avg
-32.12%
5Y Avg
-473.91%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palvella Therapeutics, Inc. (PVLA) | $1.85B | 0.00% | 0.00% | 0.00% | N/A |
| Azenta, Inc. (AZTA)vs › | $1.84B | -3.49% | -3.57% | -5.95% | -5.03% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 2.61% | 3.43% | 5.52% | 6.07% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -3084.76% | -3233.57% | -1812.12% | -1208.08% |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.88B | 0.00% | 0.00% | 0.00% | 0.00% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.82B | -29.92% | -9.23% | -24.36% | -44.57% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 29.46% | 25.49% | 21.64% | 22.06% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -1.12% | -4.89% | -11.52% | -13.12% |
| Novavax, Inc. (NVAX)vs › | $1.80B | 50.14% | 6.82% | -32.12% | -473.91% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | -873.87% | -1020.17% | -1557.98% | -1038.65% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -422.02% |
| 2023-09-30 | 15.81% |
| 2023-06-30 | 10.29% |
| 2023-03-31 | -801.19% |
